---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-000573"
form_type: "8-K"
ticker: "DHTI"
cik: "0000725394"
company_name: "Dalrada Technology Group, Inc."
filed_at: "2026-01-27T23:59:59+00:00"
generated_at: "2026-05-16T07:42:26.217382+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Dalrada subsidiary Genefic enters $20M guarantee & $5M credit facility; CEO personally guarantees

## Summary
- Genefic Inc. entered SBLC Agreement with IBS Equity Fund III for up to $20M in guarantees and related ARL Agreement for up to $5M revolving credit.
- CEO Brian Bonar provides unlimited personal guaranty for Genefic's obligations; board acknowledges potential conflicts of interest.
- Company pledges 100% equity interests in all subsidiaries and grants first-priority security interest in substantially all assets.
- Fees include $140,000 cash at closing, $165,000 promissory note (24-month $7,652 monthly), and $225,000 warrant for 5% of Genefic membership units.
- Availability period Dec 31, 2025 to Dec 31, 2030; default triggers include failure to maintain 25% collateral value and cross-defaults.

## SEC filing metadata
- accession: 0001683168-26-000573
- form_type: 8-K
- ticker: DHTI
- cik: 0000725394
- company_name: Dalrada Technology Group, Inc.
- filed_at: 2026-01-27T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/725394/000168316826000573/0001683168-26-000573-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/725394/000168316826000573/dalrada_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-000573
- JSON: https://secwatch.observer/filing/0001683168-26-000573.json
- Plain text: https://secwatch.observer/filing/0001683168-26-000573.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.